Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer

A Simplified Approach of Complete Nerve-sparing Type C1 Radical Hysterectomy for Cervical Cancer, a Phase II Study

The purpose of this study is to evaluate the feasibility of complete nerve-sparing type C1 radical hysterectomy in cervical cancer.

The primary objective of this study is to evaluate the rate of postvoid residual urine volume (PVR) <50ml on postoperative day 4 in patients with stage IB1 and IIA1 cervix cancer underwent complete nerve-sparing type C1 radical hysterectomy.

Inclusion Criteria:

• Age >=18 years to <= 70 years.
• Women with histologically confirmed, primary adenocarcinoma or squamous cell carcinoma of the uterine cervix.
• Stage IIA1, or IB1 disease.
• Karnofsky performance status >70.
• Patients who comply with follow-up.
• With written informed consent.

Exclusion Criteria:

• Age>70
• History of lower urinary tract damage or surgery.
• With abnormal urodynamic study results.
• Karnofsky performance status <70.
• Patients who have uncontrolled psychological disorders.
• Unwilling to or unable to comply with protocol.
• Prior treatment with pelvic radiotherapy